Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis - authors' reply

被引:0
作者
Yamamoto, T. [1 ]
Shimoyama, T. [1 ]
Umegae, S. [1 ]
Matsumoto, K. [1 ]
机构
[1] Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Mie, Japan
关键词
D O I
10.1111/apt.13578
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1017 / 1018
页数:2
相关论文
共 2 条
[1]   Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis [J].
Taylor, K. M. ;
Sparrow, M. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) :1016-1017
[2]   Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study [J].
Yamamoto, T. ;
Shimoyama, T. ;
Umegae, S. ;
Matsumoto, K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (06) :705-716